Dong M - Search Results

1

Conserved cell populations in doxorubicin-resistant human nasal natural killer/T cell lymphoma cell line: super multidrug resistant cells?

Zhang X, Fu X, Dong M, Yang Z, Wu S, Ma M, Li Z, Wang X, Li L, Li X, Sun Z, Chang Y, Nan F, Yan J, Mao Y, Zhang M, Chen Q. Zhang X, et al. Among authors: dong m. Cancer Cell Int. 2018 Oct 1;18:150. doi: 10.1186/s12935-018-0644-6. eCollection 2018. Cancer Cell Int. 2018. PMID: 30302057 Free PMC article.

2

Human immunodeficiency virus-negative plasmablastic lymphoma: A case report and literature review.

Lin L, Zhang X, Dong M, Li L, Wang X, Zhang L, Fu X, Sun Z, Wu J, Li Z, Chang Y, Wang Y, Zhou Z, Zhang M, Chen Q. Lin L, et al. Among authors: dong m. Medicine (Baltimore). 2017 Feb;96(7):e6171. doi: 10.1097/MD.0000000000006171. Medicine (Baltimore). 2017. PMID: 28207555 Free PMC article.

3

Patients over 40 years old with precursor T-cell lymphoblastic lymphoma have different prognostic factors comparing to the youngers.

Dong M, Zhang X, Yang Z, Wu S, Ma M, Li Z, Chang Y, Wang X, Li L, Li X, Zhang M, Chen Q. Dong M, et al. Sci Rep. 2018 Jan 18;8(1):1088. doi: 10.1038/s41598-018-19565-x. Sci Rep. 2018. PMID: 29348421 Free PMC article.

4

One method to establish Epstein-Barr virus-associated NK/T cell lymphoma mouse models.

Xue W, Li W, Shang Y, Zhang Y, Lan X, Wang G, Li Z, Zhang X, Song Y, Wu B, Dong M, Wang X, Zhang M. Xue W, et al. Among authors: dong m. J Cell Mol Med. 2019 Feb;23(2):1509-1516. doi: 10.1111/jcmm.14057. Epub 2018 Nov 28. J Cell Mol Med. 2019. PMID: 30484952 Free PMC article.

5

sATP‑binding cassette subfamily G member 2 enhances the multidrug resistance properties of human nasal natural killer/T cell lymphoma side population cells.

Wu S, Zhang X, Dong M, Yang Z, Zhang M, Chen Q. Wu S, et al. Among authors: dong m. Oncol Rep. 2020 Oct;44(4):1467-1478. doi: 10.3892/or.2020.7722. Epub 2020 Aug 10. Oncol Rep. 2020. PMID: 32945520 Free PMC article.

6

DDGP vs. SMILE in Relapsed/Refractory Extranodal Natural Killer/T-cell Lymphoma, Nasal Type: A Retrospective Study of 54 Patients.

Wang X, Hu J, Dong M, Ding M, Zhu L, Wu J, Sun Z, Li X, Zhang L, Li L, Wang X, Fu X, Wang G, Chen Q, Zhang M, Zhang X. Wang X, et al. Among authors: dong m. Clin Transl Sci. 2021 Jan;14(1):405-411. doi: 10.1111/cts.12893. Epub 2020 Oct 12. Clin Transl Sci. 2021. PMID: 33045134 Free PMC article.

7

Combination of Decitabine and a Modified Regimen of Cisplatin, Cytarabine and Dexamethasone: A Potential Salvage Regimen for Relapsed or Refractory Diffuse Large B-Cell Lymphoma After Second-Line Treatment Failure.

Hu J, Wang X, Chen F, Ding M, Dong M, Yang W, Yin M, Wu J, Zhang L, Fu X, Sun Z, Li L, Wang X, Li X, Guo S, Zhang D, Lu X, Leng Q, Zhang M, Zhu L, Zhang X, Chen Q. Hu J, et al. Among authors: dong m. Front Oncol. 2021 Jun 18;11:687374. doi: 10.3389/fonc.2021.687374. eCollection 2021. Front Oncol. 2021. PMID: 34222013 Free PMC article.

8

GPNMB promotes the progression of diffuse large B cell lymphoma via YAP1-mediated activation of the Wnt/β-catenin signaling pathway.

Wang Z, Ran X, Qian S, Hou H, Dong M, Wu S, Ding M, Zhang Y, Zhang X, Zhang M, Chen Q. Wang Z, et al. Among authors: dong m. Arch Biochem Biophys. 2021 Oct 15;710:108998. doi: 10.1016/j.abb.2021.108998. Epub 2021 Jul 17. Arch Biochem Biophys. 2021. PMID: 34280359

9

Suppression of latent transforming growth factor-β (TGF-β)-binding protein 1 (LTBP1) inhibits natural killer/ T cell lymphoma progression by inactivating the TGF-β/Smad and p38^MAPK pathways.

Lin R, Li X, Wu S, Qian S, Hou H, Dong M, Zhang X, Zhang M. Lin R, et al. Among authors: dong m. Exp Cell Res. 2021 Oct 1;407(1):112790. doi: 10.1016/j.yexcr.2021.112790. Epub 2021 Aug 18. Exp Cell Res. 2021. PMID: 34418460

10

Fotemustine-based therapy in combination with rituximab as a first-line induction chemotherapy followed by WBRT for newly diagnosed primary central nervous system lymphoma: a prospective phase II trial.

Wu J, Gao F, Wang W, Zhang X, Dong M, Zhang L, Li X, Li L, Sun Z, Wang X, Fu X, Zhu L, Ding M, Niu S, Li Z, Chang Y, Nan F, Yan J, Yu H, Wu X, Zhou Z, Zhang J, Zhang M. Wu J, et al. Among authors: dong m. Cancer Biol Med. 2021 Oct 12;19(7):1089-99. doi: 10.20892/j.issn.2095-3941.2021.0026. Online ahead of print. Cancer Biol Med. 2021. PMID: 34633776 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,464 results

Search Page

Filters